NEWS
You can follow the latest news of MicroViable in this section
Microviable obtained SME rating from EMA
The European Medicines Agency (EMA) granted the qualification of “Small and Medium-Sized Enterprises” (SME) to Microviable Therapeutics. The European Medicines Agency (EMA) provides incentives and support for micro, small and medium-sized enterprises (SMEs) that are [...]
Merry Christmas and Happy New Year
Thank you for being part of Microviable family and joining us so we can continue to grow. We wish you the best for the next holiday season and a great start of the new year!!
Meet our research intern Evelyn Villegas
Microviable wants to introduce you our research intern Evelyn Villegas, who has completed Higher Level Professional Training practices in Multiplatform Application Development in the bioinformatics area. Evelyn has also a degree from Law school and [...]
New GutAlive®, the anaerobic microbiome collection kit
Checkout our new GutAlive® !! The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. GutAlive® preserves the [...]
Microviable Therapeutics welcomes Marta Fernández on board.
Marta has a degree in Biology (2014) and a Food Biotechnology Master (2016) at the University of Oviedo, plus a MS in Microbiota, Probiotics and Prebiotics at the European University at Madrid (2021) with MS [...]
Borja Sánchez, co-founder of Microviable Therapeutics, among the 62 most influential scientists.
Asturias has 62 scientists among the most influential in the world. This has been revealed by the latest and prestigious Stanford ranking, which includes the 200,000 researchers -195,605 to be exact- most cited internationally in [...]